• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过靶向RNA依赖性RNA聚合酶的RNA干扰(RNAi)有效抑制戊型肝炎病毒在A549细胞和仔猪中的复制。

Effective inhibition of hepatitis E virus replication in A549 cells and piglets by RNA interference (RNAi) targeting RNA-dependent RNA polymerase.

作者信息

Huang Fen, Hua Xiuguo, Yang Shixing, Yuan Congli, Zhang Wen

机构信息

Zoonosis Laboratory, School of Agriculture and Biology, Shanghai Jiao Tong University, Shanghai, PR China.

出版信息

Antiviral Res. 2009 Sep;83(3):274-81. doi: 10.1016/j.antiviral.2009.06.008. Epub 2009 Jul 1.

DOI:10.1016/j.antiviral.2009.06.008
PMID:19576249
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7114333/
Abstract

RNA interference (RNAi) is a natural mechanism for suppressing or silencing expression of aberrant or foreign genes. It is a powerful antiviral strategy that has been widely employed to protect hosts from viral infection. Hepatitis E (HE) is an acute fulminant hepatitis in adults that has particularly high mortality in pregnant women. At this point in time, there is no vaccine or antiviral treatment that is effective against the infectious agent, HEV. The nonstructural polyprotein region possesses an RNA-dependent RNA polymerase (RdRp) that is responsible for the replication of the viral RNA genome. RdRp is therefore regarded as one of the most attractive candidates for RNA interference (RNAi). In the present study, the high efficiency and specificity of siRNA were evaluated by Real-Time quantitative PCR and Western blot assays. Protective effects against HEV infection were achieved in A549 cells and in piglets. In piglets treated with a shRNA-RdRp-1 expression plasmid prior to HEV inoculation, HEV antigens were significantly reduced in the liver, spleen, and kidneys, and the activities of alanine aminotransferase (ALT), aspartate aminotransferase (AST) and total bilirubin (TBIL) were clearly decreased. These results suggested that RNAi is a potentially effective antiviral strategy against HEV replication and infection.

摘要

RNA干扰(RNAi)是一种抑制或沉默异常或外源基因表达的天然机制。它是一种强大的抗病毒策略,已被广泛用于保护宿主免受病毒感染。戊型肝炎(HE)是一种成人急性暴发性肝炎,在孕妇中死亡率特别高。目前,尚无针对戊型肝炎病毒(HEV)这种感染因子的有效疫苗或抗病毒治疗方法。非结构多聚蛋白区域拥有一种依赖RNA的RNA聚合酶(RdRp),它负责病毒RNA基因组的复制。因此,RdRp被认为是RNA干扰(RNAi)最具吸引力的候选靶点之一。在本研究中,通过实时定量PCR和蛋白质印迹分析评估了小干扰RNA(siRNA)的高效性和特异性。在A549细胞和仔猪中实现了对HEV感染的保护作用。在用shRNA-RdRp-1表达质粒预处理的仔猪中,接种HEV后,肝脏、脾脏和肾脏中的HEV抗原显著减少,丙氨酸转氨酶(ALT)、天冬氨酸转氨酶(AST)和总胆红素(TBIL)的活性明显降低。这些结果表明,RNAi是一种针对HEV复制和感染的潜在有效抗病毒策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b253/7114333/baa90437838f/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b253/7114333/dc0b5e936664/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b253/7114333/27e79763ed01/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b253/7114333/b5c2c76906c5/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b253/7114333/89c799501c5b/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b253/7114333/baa90437838f/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b253/7114333/dc0b5e936664/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b253/7114333/27e79763ed01/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b253/7114333/b5c2c76906c5/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b253/7114333/89c799501c5b/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b253/7114333/baa90437838f/gr5.jpg

相似文献

1
Effective inhibition of hepatitis E virus replication in A549 cells and piglets by RNA interference (RNAi) targeting RNA-dependent RNA polymerase.通过靶向RNA依赖性RNA聚合酶的RNA干扰(RNAi)有效抑制戊型肝炎病毒在A549细胞和仔猪中的复制。
Antiviral Res. 2009 Sep;83(3):274-81. doi: 10.1016/j.antiviral.2009.06.008. Epub 2009 Jul 1.
2
Zinc Salts Block Hepatitis E Virus Replication by Inhibiting the Activity of Viral RNA-Dependent RNA Polymerase.锌盐通过抑制病毒RNA依赖性RNA聚合酶的活性来阻断戊型肝炎病毒复制。
J Virol. 2017 Oct 13;91(21). doi: 10.1128/JVI.00754-17. Print 2017 Nov 1.
3
Combining RNA Interference and RIG-I Activation to Inhibit Hepatitis E Virus Replication.联合 RNA 干扰和 RIG-I 激活抑制戊型肝炎病毒复制。
Viruses. 2024 Aug 29;16(9):1378. doi: 10.3390/v16091378.
4
Inhibition of Hepatitis E virus replication using short hairpin RNA (shRNA).利用短发夹 RNA(shRNA)抑制戊型肝炎病毒复制。
Antiviral Res. 2010 Mar;85(3):541-50. doi: 10.1016/j.antiviral.2010.01.005. Epub 2010 Jan 25.
5
An ethanol extract of Lysimachia mauritiana exhibits inhibitory activity against hepatitis E virus genotype 3 replication.岗梅乙醇提取物对戊型肝炎病毒 3 型的复制具有抑制活性。
J Microbiol. 2017 Dec;55(12):984-988. doi: 10.1007/s12275-017-7477-1. Epub 2017 Dec 7.
6
Calcineurin inhibitors stimulate and mycophenolic acid inhibits replication of hepatitis E virus.钙调磷酸酶抑制剂可刺激,而霉酚酸可抑制戊型肝炎病毒的复制。
Gastroenterology. 2014 Jun;146(7):1775-83. doi: 10.1053/j.gastro.2014.02.036. Epub 2014 Feb 26.
7
Inhibition of hepatitis E virus replication by proteasome inhibitor is nonspecific.蛋白酶体抑制剂对戊型肝炎病毒复制的抑制作用是非特异性的。
Arch Virol. 2015 Feb;160(2):435-9. doi: 10.1007/s00705-014-2303-0. Epub 2014 Dec 5.
8
The natural compound silvestrol inhibits hepatitis E virus (HEV) replication in vitro and in vivo.天然化合物表没食子儿茶素没食子酸酯在体外和体内抑制戊型肝炎病毒(HEV)复制。
Antiviral Res. 2018 Sep;157:151-158. doi: 10.1016/j.antiviral.2018.07.010. Epub 2018 Jul 20.
9
RNA interference inhibits hepatitis E virus mRNA accumulation and protein synthesis in vitro.RNA 干扰抑制体外戊型肝炎病毒 mRNA 的积累和蛋白质合成。
Vet Microbiol. 2010 May 19;142(3-4):261-7. doi: 10.1016/j.vetmic.2009.10.023. Epub 2009 Nov 6.
10
Antiviral Candidates for Treating Hepatitis E Virus Infection.抗戊型肝炎病毒药物治疗的候选药物。
Antimicrob Agents Chemother. 2019 May 24;63(6). doi: 10.1128/AAC.00003-19. Print 2019 Jun.

引用本文的文献

1
Combining RNA Interference and RIG-I Activation to Inhibit Hepatitis E Virus Replication.联合 RNA 干扰和 RIG-I 激活抑制戊型肝炎病毒复制。
Viruses. 2024 Aug 29;16(9):1378. doi: 10.3390/v16091378.
2
Characteristics and Functions of HEV Proteins.戊型肝炎病毒蛋白的特性与功能。
Adv Exp Med Biol. 2023;1417:15-32. doi: 10.1007/978-981-99-1304-6_2.
3
Influenza A Virus Production in Mouse Lung Is Inhibited by Inhalation of Aerosol Polyethylenimine/Short Hairpin RNA Plasmid Complexes.气溶胶聚乙烯亚胺/短发夹 RNA 质粒复合物经呼吸道吸入抑制小鼠肺部流感病毒的生成。

本文引用的文献

1
RNA silencing and HIV: a hypothesis for the etiology of the severe combined immunodeficiency induced by the virus.RNA沉默与艾滋病病毒:关于该病毒所致严重联合免疫缺陷病因的一种假说
Retrovirology. 2008 Sep 11;5:79. doi: 10.1186/1742-4690-5-79.
2
Origins and evolution of eukaryotic RNA interference.真核生物RNA干扰的起源与进化
Trends Ecol Evol. 2008 Oct;23(10):578-87. doi: 10.1016/j.tree.2008.06.005. Epub 2008 Aug 18.
3
T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice.T细胞特异性小干扰RNA的递送可抑制人源化小鼠中的HIV-1感染。
Dis Markers. 2022 Apr 22;2022:7404813. doi: 10.1155/2022/7404813. eCollection 2022.
4
An RNA Interference/Adeno-Associated Virus Vector-Based Combinatorial Gene Therapy Approach Against Hepatitis E Virus.基于 RNA 干扰/腺相关病毒载体的组合基因治疗方法抗戊型肝炎病毒。
Hepatol Commun. 2022 Apr;6(4):878-888. doi: 10.1002/hep4.1842. Epub 2021 Oct 31.
5
Hepatitis E Virus Replication.戊型肝炎病毒复制。
Viruses. 2019 Aug 6;11(8):719. doi: 10.3390/v11080719.
6
Successful infection of BALB/c mice by a swine hepatitis E virus clone constructed with reverse genetics.利用反向遗传学构建的猪戊型肝炎病毒克隆成功感染 BALB/c 小鼠。
BMC Infect Dis. 2018 Dec 20;18(1):687. doi: 10.1186/s12879-018-3544-4.
7
A review on current status of antiviral siRNA.抗病毒 siRNA 的研究现状综述。
Rev Med Virol. 2018 Jul;28(4):e1976. doi: 10.1002/rmv.1976. Epub 2018 Apr 15.
8
Molecular Biology and Infection of Hepatitis E Virus.戊型肝炎病毒的分子生物学与感染
Front Microbiol. 2016 Sep 7;7:1419. doi: 10.3389/fmicb.2016.01419. eCollection 2016.
9
Hepatitis E virus infection activates signal regulator protein α to down-regulate type I interferon.戊型肝炎病毒感染激活信号调节蛋白α以下调I型干扰素。
Immunol Res. 2016 Feb;64(1):115-22. doi: 10.1007/s12026-015-8729-y.
10
Therapeutic targets for the treatment of hepatitis E virus infection.戊型肝炎病毒感染的治疗靶点
Expert Opin Ther Targets. 2015;19(9):1245-60. doi: 10.1517/14728222.2015.1056155. Epub 2015 Jun 13.
Cell. 2008 Aug 22;134(4):577-86. doi: 10.1016/j.cell.2008.06.034. Epub 2008 Aug 7.
4
Evaluation of safety and efficacy of RNAi against HIV-1 in the human immune system (Rag-2(-/-)gammac(-/-)) mouse model.在人类免疫系统(Rag-2(-/-)gammac(-/-))小鼠模型中评估RNA干扰对HIV-1的安全性和有效性。
Gene Ther. 2009 Jan;16(1):148-53. doi: 10.1038/gt.2008.124. Epub 2008 Jul 31.
5
Mutational events during the primary propagation and consecutive passages of hepatitis E virus strain JE03-1760F in cell culture.戊型肝炎病毒株JE03 - 1760F在细胞培养中的初次传代及连续传代过程中的突变事件。
Virus Res. 2008 Oct;137(1):86-96. doi: 10.1016/j.virusres.2008.06.005. Epub 2008 Jul 26.
6
The efficacy of generating three independent anti-HIV-1 siRNAs from a single U6 RNA Pol III-expressed long hairpin RNA.从单个由U6 RNA聚合酶III表达的长发夹RNA产生三种独立的抗HIV-1 siRNA的效果。
PLoS One. 2008 Jul 2;3(7):e2602. doi: 10.1371/journal.pone.0002602.
7
Cross-species infection of specific-pathogen-free pigs by a genotype 4 strain of human hepatitis E virus.人戊型肝炎病毒4型毒株对无特定病原体猪的跨物种感染。
J Med Virol. 2008 Aug;80(8):1379-86. doi: 10.1002/jmv.21223.
8
Harnessing the RNA interference pathway to advance treatment and prevention of hepatocellular carcinoma.利用RNA干扰途径推进肝细胞癌的治疗与预防。
World J Gastroenterol. 2008 Mar 21;14(11):1670-81. doi: 10.3748/wjg.14.1670.
9
[Viral hepatitis in travellers].[旅行者中的病毒性肝炎]
Acta Med Port. 2007 Nov-Dec;20(6):557-66. Epub 2008 Feb 13.
10
Macaque models of human infectious disease.人类传染病的猕猴模型。
ILAR J. 2008;49(2):220-55. doi: 10.1093/ilar.49.2.220.